Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid beta-Peptides | 106 | 2023 | 3840 | 7.730 |
Why?
|
Alzheimer Disease | 81 | 2023 | 8603 | 4.030 |
Why?
|
tau Proteins | 21 | 2023 | 2094 | 3.220 |
Why?
|
Peptide Fragments | 41 | 2021 | 5103 | 2.470 |
Why?
|
Amyloid beta-Protein Precursor | 25 | 2018 | 1111 | 2.360 |
Why?
|
Synapses | 22 | 2023 | 1755 | 1.710 |
Why?
|
Long-Term Potentiation | 25 | 2023 | 290 | 1.650 |
Why?
|
Neurodegenerative Diseases | 7 | 2021 | 1085 | 1.570 |
Why?
|
Neuronal Plasticity | 19 | 2023 | 1432 | 1.440 |
Why?
|
Neurons | 29 | 2023 | 9428 | 1.190 |
Why?
|
Prions | 7 | 2023 | 177 | 1.130 |
Why?
|
Brain | 35 | 2023 | 27092 | 1.090 |
Why?
|
Neurotoxins | 5 | 2015 | 240 | 1.090 |
Why?
|
Plaque, Amyloid | 11 | 2019 | 762 | 1.010 |
Why?
|
Neurofilament Proteins | 3 | 2021 | 334 | 0.960 |
Why?
|
Amyloid Precursor Protein Secretases | 9 | 2014 | 619 | 0.920 |
Why?
|
Creutzfeldt-Jakob Syndrome | 2 | 2021 | 92 | 0.890 |
Why?
|
Hippocampus | 26 | 2023 | 3754 | 0.830 |
Why?
|
Amyloid | 9 | 2018 | 848 | 0.740 |
Why?
|
Protein Multimerization | 6 | 2019 | 974 | 0.740 |
Why?
|
Antibodies | 4 | 2018 | 2415 | 0.720 |
Why?
|
PrPC Proteins | 5 | 2023 | 35 | 0.650 |
Why?
|
Antibodies, Monoclonal | 11 | 2018 | 9187 | 0.640 |
Why?
|
Immunoassay | 2 | 2021 | 743 | 0.630 |
Why?
|
CHO Cells | 21 | 2018 | 1379 | 0.630 |
Why?
|
alpha-Synuclein | 5 | 2019 | 742 | 0.630 |
Why?
|
Water | 3 | 2015 | 1410 | 0.590 |
Why?
|
Nootropic Agents | 2 | 2015 | 157 | 0.560 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 11 | 2015 | 3803 | 0.510 |
Why?
|
Rats | 43 | 2023 | 23704 | 0.500 |
Why?
|
Memory Disorders | 4 | 2015 | 1198 | 0.490 |
Why?
|
Immunization, Passive | 2 | 2015 | 617 | 0.480 |
Why?
|
Cystine | 1 | 2015 | 93 | 0.480 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2015 | 54 | 0.480 |
Why?
|
Recombinant Proteins | 7 | 2018 | 6504 | 0.480 |
Why?
|
Rats, Wistar | 14 | 2017 | 1848 | 0.480 |
Why?
|
Animals | 95 | 2023 | 168079 | 0.470 |
Why?
|
Molecular Weight | 9 | 2018 | 2171 | 0.470 |
Why?
|
Dimerization | 10 | 2016 | 887 | 0.470 |
Why?
|
Brain Chemistry | 6 | 2017 | 959 | 0.460 |
Why?
|
Genetic Markers | 1 | 2020 | 2599 | 0.460 |
Why?
|
Cricetinae | 19 | 2014 | 2412 | 0.450 |
Why?
|
Cricetulus | 12 | 2018 | 812 | 0.440 |
Why?
|
Nerve Tissue Proteins | 6 | 2014 | 4404 | 0.430 |
Why?
|
Photosystem II Protein Complex | 1 | 2012 | 18 | 0.420 |
Why?
|
Chromatography, Gel | 11 | 2018 | 641 | 0.420 |
Why?
|
Immunoprecipitation | 9 | 2015 | 874 | 0.410 |
Why?
|
Neurofibrillary Tangles | 2 | 2016 | 457 | 0.410 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 7 | 2015 | 1728 | 0.410 |
Why?
|
Aspartic Acid Endopeptidases | 4 | 2010 | 309 | 0.410 |
Why?
|
Culture Media, Conditioned | 8 | 2015 | 522 | 0.400 |
Why?
|
Avoidance Learning | 2 | 2012 | 247 | 0.390 |
Why?
|
Endopeptidases | 5 | 2003 | 766 | 0.390 |
Why?
|
Down Syndrome | 1 | 2020 | 901 | 0.380 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 22127 | 0.360 |
Why?
|
Synaptic Transmission | 3 | 2014 | 1167 | 0.360 |
Why?
|
Excitatory Postsynaptic Potentials | 7 | 2017 | 369 | 0.350 |
Why?
|
Long-Term Synaptic Depression | 3 | 2019 | 59 | 0.350 |
Why?
|
Protein Binding | 12 | 2021 | 9297 | 0.340 |
Why?
|
Circular Dichroism | 9 | 2016 | 334 | 0.340 |
Why?
|
Neprilysin | 4 | 2008 | 478 | 0.340 |
Why?
|
Solubility | 11 | 2015 | 1085 | 0.330 |
Why?
|
Fenofibrate | 1 | 2009 | 87 | 0.330 |
Why?
|
Mice | 43 | 2023 | 81326 | 0.330 |
Why?
|
Protease Inhibitors | 3 | 2009 | 752 | 0.320 |
Why?
|
Mice, Transgenic | 17 | 2023 | 9520 | 0.310 |
Why?
|
Amino Acid Sequence | 19 | 2021 | 13402 | 0.310 |
Why?
|
Frontal Lobe | 1 | 2015 | 1416 | 0.310 |
Why?
|
Extracellular Space | 3 | 2018 | 563 | 0.310 |
Why?
|
Glutamic Acid | 7 | 2019 | 1173 | 0.300 |
Why?
|
Temporal Lobe | 2 | 2015 | 1695 | 0.300 |
Why?
|
Blotting, Western | 9 | 2015 | 5032 | 0.300 |
Why?
|
Humans | 112 | 2023 | 761208 | 0.290 |
Why?
|
Aged, 80 and over | 20 | 2021 | 58952 | 0.280 |
Why?
|
Cerebellum | 1 | 2014 | 1501 | 0.280 |
Why?
|
Organ Culture Techniques | 3 | 2019 | 793 | 0.270 |
Why?
|
CA1 Region, Hippocampal | 2 | 2019 | 109 | 0.270 |
Why?
|
Kinetics | 10 | 2015 | 6312 | 0.260 |
Why?
|
Parkinson Disease | 5 | 2010 | 2867 | 0.260 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2018 | 1852 | 0.240 |
Why?
|
Male | 58 | 2023 | 360693 | 0.240 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3696 | 0.230 |
Why?
|
Immunotherapy | 2 | 2023 | 4642 | 0.230 |
Why?
|
Molecular Sequence Data | 16 | 2015 | 17598 | 0.230 |
Why?
|
Aged | 23 | 2021 | 169288 | 0.220 |
Why?
|
Protein Conformation | 9 | 2014 | 3933 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2009 | 2270 | 0.210 |
Why?
|
Polymers | 6 | 2012 | 1617 | 0.200 |
Why?
|
Spectrometry, Fluorescence | 2 | 2015 | 683 | 0.200 |
Why?
|
Sodium Dodecyl Sulfate | 4 | 2012 | 124 | 0.200 |
Why?
|
Mass Spectrometry | 3 | 2016 | 2189 | 0.200 |
Why?
|
Mice, Inbred DBA | 2 | 2015 | 623 | 0.190 |
Why?
|
Longevity | 1 | 2009 | 1063 | 0.190 |
Why?
|
Injections, Intraventricular | 5 | 2014 | 225 | 0.190 |
Why?
|
Exosomes | 2 | 2018 | 424 | 0.190 |
Why?
|
Amino Acid Substitution | 4 | 2014 | 1737 | 0.180 |
Why?
|
Oxygen | 1 | 2012 | 4227 | 0.180 |
Why?
|
Insulysin | 4 | 2008 | 49 | 0.180 |
Why?
|
Female | 44 | 2021 | 392544 | 0.180 |
Why?
|
Aminoacyltransferases | 1 | 2021 | 52 | 0.180 |
Why?
|
Disease Models, Animal | 11 | 2019 | 18220 | 0.180 |
Why?
|
Intracellular Fluid | 1 | 2000 | 201 | 0.180 |
Why?
|
Microscopy, Electron | 9 | 2012 | 2561 | 0.170 |
Why?
|
Mutation | 9 | 2018 | 30002 | 0.170 |
Why?
|
Protein Structure, Secondary | 7 | 2013 | 1216 | 0.170 |
Why?
|
Cysteine Endopeptidases | 2 | 2021 | 551 | 0.160 |
Why?
|
Protein Structure, Tertiary | 5 | 2010 | 3778 | 0.160 |
Why?
|
Cognition Disorders | 3 | 2010 | 3976 | 0.160 |
Why?
|
Microscopy, Electron, Transmission | 4 | 2015 | 696 | 0.160 |
Why?
|
Cell Death | 4 | 2018 | 1676 | 0.150 |
Why?
|
Light | 3 | 2012 | 1348 | 0.150 |
Why?
|
Developmental Disabilities | 1 | 2007 | 1510 | 0.150 |
Why?
|
PrPSc Proteins | 1 | 2017 | 28 | 0.150 |
Why?
|
Cross-Linking Reagents | 2 | 2011 | 684 | 0.150 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2802 | 0.150 |
Why?
|
Cells, Cultured | 13 | 2014 | 18926 | 0.140 |
Why?
|
Drug Contamination | 1 | 2018 | 151 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 5 | 2016 | 1535 | 0.140 |
Why?
|
Memory | 3 | 2014 | 2190 | 0.140 |
Why?
|
Middle Aged | 15 | 2021 | 220853 | 0.140 |
Why?
|
Transfection | 5 | 2010 | 5748 | 0.140 |
Why?
|
Neural Inhibition | 2 | 2011 | 586 | 0.130 |
Why?
|
Growth Hormone | 1 | 2018 | 569 | 0.130 |
Why?
|
Disease Progression | 4 | 2021 | 13511 | 0.130 |
Why?
|
Microsomes | 2 | 2009 | 251 | 0.130 |
Why?
|
Presynaptic Terminals | 2 | 2016 | 302 | 0.130 |
Why?
|
Electrophysiology | 5 | 2011 | 1262 | 0.130 |
Why?
|
Iatrogenic Disease | 1 | 2018 | 539 | 0.120 |
Why?
|
Microscopy | 2 | 2018 | 904 | 0.120 |
Why?
|
Protein Denaturation | 3 | 2011 | 241 | 0.120 |
Why?
|
Infusions, Parenteral | 1 | 2015 | 398 | 0.120 |
Why?
|
Metalloendopeptidases | 2 | 1994 | 389 | 0.120 |
Why?
|
Tauopathies | 1 | 2018 | 320 | 0.120 |
Why?
|
Cadaver | 1 | 2018 | 1358 | 0.120 |
Why?
|
Escherichia coli | 3 | 2021 | 4201 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2003 | 2881 | 0.120 |
Why?
|
Antibody Specificity | 2 | 2014 | 1059 | 0.120 |
Why?
|
Immunoglobulin G | 3 | 2015 | 4537 | 0.110 |
Why?
|
Fluorescence | 1 | 2016 | 751 | 0.110 |
Why?
|
Gelatinases | 1 | 1994 | 88 | 0.110 |
Why?
|
Cerebral Cortex | 5 | 2011 | 5775 | 0.110 |
Why?
|
Neurites | 2 | 2018 | 391 | 0.110 |
Why?
|
Ultracentrifugation | 2 | 2011 | 182 | 0.110 |
Why?
|
Substrate Specificity | 3 | 2021 | 1768 | 0.110 |
Why?
|
Cell Membrane | 1 | 2003 | 3661 | 0.110 |
Why?
|
Scattering, Radiation | 2 | 2010 | 490 | 0.110 |
Why?
|
Tissue Extracts | 2 | 2011 | 139 | 0.110 |
Why?
|
Maze Learning | 1 | 2015 | 481 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2015 | 11067 | 0.110 |
Why?
|
Age of Onset | 1 | 2020 | 3307 | 0.110 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2013 | 894 | 0.110 |
Why?
|
Peptide Hydrolases | 2 | 2008 | 616 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 6 | 2015 | 8164 | 0.110 |
Why?
|
Solar Energy | 1 | 2012 | 8 | 0.110 |
Why?
|
Models, Biological | 6 | 2018 | 9457 | 0.110 |
Why?
|
Synaptic Vesicles | 1 | 2014 | 190 | 0.100 |
Why?
|
Cell Line | 5 | 2017 | 15545 | 0.100 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2015 | 166 | 0.100 |
Why?
|
Nanotubes | 1 | 2013 | 82 | 0.100 |
Why?
|
Apolipoproteins E | 1 | 2018 | 1443 | 0.100 |
Why?
|
Prealbumin | 1 | 2014 | 247 | 0.100 |
Why?
|
Protein Folding | 2 | 2010 | 869 | 0.100 |
Why?
|
Microglia | 2 | 2020 | 1358 | 0.100 |
Why?
|
Epitopes | 3 | 2014 | 2504 | 0.100 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 509 | 0.100 |
Why?
|
Calpain | 1 | 2012 | 146 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2017 | 14392 | 0.090 |
Why?
|
Simvastatin | 1 | 2014 | 346 | 0.090 |
Why?
|
Molecular Conformation | 1 | 2012 | 543 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.090 |
Why?
|
Pluripotent Stem Cells | 1 | 2018 | 794 | 0.090 |
Why?
|
Vitamin E Deficiency | 1 | 1991 | 30 | 0.090 |
Why?
|
Catalysis | 1 | 2012 | 763 | 0.090 |
Why?
|
Molecular Structure | 2 | 2015 | 1875 | 0.090 |
Why?
|
Cerebral Amyloid Angiopathy | 3 | 2015 | 893 | 0.090 |
Why?
|
Immunization | 2 | 2005 | 1218 | 0.090 |
Why?
|
Binding Sites | 3 | 2021 | 5988 | 0.090 |
Why?
|
Flurbiprofen | 1 | 2009 | 21 | 0.090 |
Why?
|
Protein Transport | 1 | 2016 | 1958 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14675 | 0.090 |
Why?
|
Benzodiazepinones | 1 | 2009 | 50 | 0.090 |
Why?
|
Lipid Peroxidation | 1 | 1991 | 271 | 0.090 |
Why?
|
Synucleins | 3 | 2004 | 108 | 0.090 |
Why?
|
Congo Red | 5 | 2004 | 48 | 0.090 |
Why?
|
MicroRNAs | 2 | 2018 | 3758 | 0.090 |
Why?
|
Presenilin-1 | 4 | 2018 | 660 | 0.080 |
Why?
|
Glutathione Peroxidase | 1 | 1991 | 258 | 0.080 |
Why?
|
Manganese | 1 | 2012 | 391 | 0.080 |
Why?
|
Treatment Failure | 2 | 2014 | 2643 | 0.080 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 306 | 0.080 |
Why?
|
Oxazines | 1 | 2011 | 349 | 0.080 |
Why?
|
Biocatalysis | 1 | 2009 | 168 | 0.080 |
Why?
|
Models, Molecular | 4 | 2011 | 5406 | 0.080 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1139 | 0.080 |
Why?
|
Nanoparticles | 2 | 2012 | 1959 | 0.080 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 2227 | 0.080 |
Why?
|
Apoptosis | 2 | 2016 | 9477 | 0.080 |
Why?
|
Calcium Carbonate | 1 | 2009 | 62 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5782 | 0.080 |
Why?
|
Acupuncture, Ear | 1 | 2008 | 13 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2010 | 1168 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2014 | 1047 | 0.080 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 400 | 0.080 |
Why?
|
Fibrinolysin | 1 | 2008 | 130 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2015 | 886 | 0.070 |
Why?
|
Selenium | 1 | 1991 | 416 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2223 | 0.070 |
Why?
|
Dipeptides | 1 | 2009 | 386 | 0.070 |
Why?
|
Cohort Studies | 3 | 2020 | 41496 | 0.070 |
Why?
|
Protease Nexins | 1 | 2007 | 39 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3836 | 0.070 |
Why?
|
Protons | 1 | 2012 | 1111 | 0.070 |
Why?
|
Nanotechnology | 1 | 2012 | 713 | 0.070 |
Why?
|
Biophysics | 3 | 2014 | 379 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6857 | 0.070 |
Why?
|
Vitamin E | 1 | 1991 | 872 | 0.070 |
Why?
|
Immunoglobulin M | 1 | 2011 | 1527 | 0.070 |
Why?
|
Drug Synergism | 1 | 2010 | 1756 | 0.070 |
Why?
|
PC12 Cells | 3 | 2000 | 317 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3320 | 0.070 |
Why?
|
Chromosome Pairing | 1 | 2006 | 45 | 0.070 |
Why?
|
Signal Transduction | 5 | 2018 | 23416 | 0.060 |
Why?
|
Inositol | 1 | 2006 | 215 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4340 | 0.060 |
Why?
|
Peptides | 2 | 2012 | 4353 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.060 |
Why?
|
Calcium | 4 | 2014 | 5719 | 0.060 |
Why?
|
Microspheres | 1 | 2009 | 783 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7571 | 0.060 |
Why?
|
Diamines | 1 | 2005 | 60 | 0.060 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 956 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2897 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2009 | 1695 | 0.060 |
Why?
|
Muscular Diseases | 2 | 1999 | 552 | 0.060 |
Why?
|
Thiazoles | 3 | 2019 | 1517 | 0.060 |
Why?
|
Electric Stimulation | 4 | 2014 | 1736 | 0.060 |
Why?
|
Patch-Clamp Techniques | 3 | 2015 | 924 | 0.060 |
Why?
|
Reference Values | 2 | 2007 | 4921 | 0.060 |
Why?
|
Bone Transplantation | 1 | 2009 | 923 | 0.060 |
Why?
|
Lewy Body Disease | 2 | 2003 | 247 | 0.060 |
Why?
|
Rabbits | 2 | 2009 | 4750 | 0.060 |
Why?
|
Phosphorylation | 4 | 2020 | 8300 | 0.050 |
Why?
|
Models, Neurological | 1 | 2012 | 1769 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2003 | 66 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2018 | 22174 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3620 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12976 | 0.050 |
Why?
|
Pyridazines | 1 | 2005 | 202 | 0.050 |
Why?
|
Glycine | 3 | 2004 | 659 | 0.050 |
Why?
|
Benzothiazoles | 2 | 2015 | 248 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 2 | 2018 | 1967 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2018 | 11509 | 0.050 |
Why?
|
Valine | 1 | 2004 | 408 | 0.050 |
Why?
|
Behavior | 1 | 2005 | 540 | 0.050 |
Why?
|
Autophagy | 1 | 2010 | 1327 | 0.050 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2004 | 195 | 0.050 |
Why?
|
Gene Deletion | 1 | 2010 | 2658 | 0.050 |
Why?
|
Drug Administration Routes | 2 | 2014 | 150 | 0.050 |
Why?
|
Coloring Agents | 3 | 2000 | 561 | 0.050 |
Why?
|
Osteogenesis | 1 | 2009 | 1273 | 0.050 |
Why?
|
Age Factors | 4 | 2016 | 18384 | 0.050 |
Why?
|
Adult | 8 | 2021 | 221119 | 0.050 |
Why?
|
COS Cells | 1 | 2003 | 1129 | 0.050 |
Why?
|
Helix-Turn-Helix Motifs | 1 | 2000 | 14 | 0.050 |
Why?
|
Pilot Projects | 2 | 2012 | 8642 | 0.050 |
Why?
|
Exercise Therapy | 1 | 2008 | 922 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 8998 | 0.050 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2004 | 655 | 0.040 |
Why?
|
Alanine | 2 | 2001 | 608 | 0.040 |
Why?
|
Extracellular Fluid | 2 | 2013 | 165 | 0.040 |
Why?
|
Cell-Free System | 1 | 2000 | 336 | 0.040 |
Why?
|
Threonine | 1 | 2020 | 270 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2014 | 6223 | 0.040 |
Why?
|
Antibody Formation | 1 | 2004 | 1391 | 0.040 |
Why?
|
Two-Hybrid System Techniques | 1 | 2021 | 459 | 0.040 |
Why?
|
Infant | 2 | 2020 | 36169 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6199 | 0.040 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 159 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 540 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2009 | 446 | 0.040 |
Why?
|
Low Back Pain | 1 | 2008 | 983 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1240 | 0.040 |
Why?
|
Amyloidosis | 1 | 2006 | 865 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2009 | 1865 | 0.040 |
Why?
|
Hydrolysis | 2 | 1998 | 652 | 0.040 |
Why?
|
Receptors, Neurokinin-2 | 2 | 1995 | 24 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 450 | 0.040 |
Why?
|
Analgesics | 2 | 2008 | 1068 | 0.040 |
Why?
|
Time Factors | 9 | 2017 | 39957 | 0.040 |
Why?
|
Child | 3 | 2020 | 80152 | 0.040 |
Why?
|
Aspartate Aminotransferase, Cytoplasmic | 1 | 2017 | 2 | 0.040 |
Why?
|
Base Sequence | 1 | 2009 | 12404 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4167 | 0.040 |
Why?
|
Brain Diseases | 1 | 2006 | 1545 | 0.040 |
Why?
|
Body Temperature | 1 | 2000 | 780 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42224 | 0.030 |
Why?
|
Ultrasonic Therapy | 1 | 1999 | 215 | 0.030 |
Why?
|
Synaptosomes | 1 | 2017 | 116 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2017 | 413 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 71 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 88298 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 2016 | 317 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14610 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 217 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2010 | 10756 | 0.030 |
Why?
|
Phototherapy | 1 | 1999 | 368 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 282 | 0.030 |
Why?
|
Ligands | 2 | 2013 | 3264 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59221 | 0.030 |
Why?
|
Microscopy, Atomic Force | 2 | 2010 | 252 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20119 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11856 | 0.030 |
Why?
|
Fatty Acids | 1 | 2003 | 1807 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 574 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 370 | 0.030 |
Why?
|
Ultrasonics | 1 | 1996 | 207 | 0.030 |
Why?
|
Receptors, Neurokinin-3 | 1 | 1994 | 59 | 0.030 |
Why?
|
Naphthalenes | 1 | 2015 | 198 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 289 | 0.030 |
Why?
|
Neurokinin B | 1 | 1994 | 67 | 0.030 |
Why?
|
Buffers | 1 | 2014 | 143 | 0.030 |
Why?
|
Oligopeptides | 3 | 1995 | 1179 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2014 | 89 | 0.030 |
Why?
|
Dementia | 3 | 2015 | 2684 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2018 | 747 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 2916 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2016 | 419 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2015 | 150 | 0.030 |
Why?
|
Acrylamides | 1 | 2015 | 259 | 0.030 |
Why?
|
Normal Distribution | 1 | 2014 | 272 | 0.030 |
Why?
|
Prospective Studies | 2 | 2020 | 54435 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 561 | 0.030 |
Why?
|
Fetus | 1 | 2000 | 1864 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9416 | 0.030 |
Why?
|
Serum | 1 | 2014 | 208 | 0.030 |
Why?
|
Exocytosis | 1 | 2014 | 320 | 0.030 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1992 | 89 | 0.030 |
Why?
|
Drug Interactions | 2 | 2009 | 1417 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2013 | 150 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2014 | 489 | 0.020 |
Why?
|
Cross Reactions | 1 | 2014 | 819 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1963 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2014 | 412 | 0.020 |
Why?
|
Diffusion | 1 | 2013 | 813 | 0.020 |
Why?
|
Laser Therapy | 1 | 1999 | 1094 | 0.020 |
Why?
|
Pain Measurement | 4 | 2008 | 3549 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2013 | 427 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 1994 | 328 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 1994 | 459 | 0.020 |
Why?
|
Acetylcholine | 1 | 2013 | 629 | 0.020 |
Why?
|
Metals | 1 | 1996 | 711 | 0.020 |
Why?
|
Deafness | 1 | 2015 | 460 | 0.020 |
Why?
|
Receptors, Dopamine D1 | 1 | 1992 | 292 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2013 | 544 | 0.020 |
Why?
|
Tomography | 1 | 2013 | 411 | 0.020 |
Why?
|
Phosphates | 1 | 2014 | 763 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 494 | 0.020 |
Why?
|
Binding, Competitive | 3 | 1998 | 1140 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 396 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1256 | 0.020 |
Why?
|
Silver Staining | 1 | 2010 | 62 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2224 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 2667 | 0.020 |
Why?
|
Neurofibrils | 1 | 2009 | 75 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 613 | 0.020 |
Why?
|
Incidence | 1 | 2008 | 21365 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 1992 | 485 | 0.020 |
Why?
|
Particle Size | 1 | 2014 | 1649 | 0.020 |
Why?
|
Ryanodine | 1 | 2009 | 46 | 0.020 |
Why?
|
Drug Stability | 1 | 2010 | 288 | 0.020 |
Why?
|
Freeze Drying | 2 | 2000 | 101 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 731 | 0.020 |
Why?
|
Bicuculline | 1 | 2009 | 96 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2012 | 850 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2012 | 811 | 0.020 |
Why?
|
GABA Antagonists | 1 | 2009 | 119 | 0.020 |
Why?
|
Cataract | 1 | 2015 | 828 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15841 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1644 | 0.020 |
Why?
|
Range of Motion, Articular | 3 | 2000 | 1590 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.020 |
Why?
|
Bone Matrix | 1 | 2009 | 118 | 0.020 |
Why?
|
Muscle Fatigue | 2 | 1999 | 95 | 0.020 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1994 | 732 | 0.020 |
Why?
|
Osteocalcin | 1 | 2009 | 274 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 668 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2008 | 239 | 0.020 |
Why?
|
Lentivirus | 1 | 2011 | 508 | 0.020 |
Why?
|
Pain | 2 | 2000 | 5072 | 0.020 |
Why?
|
Learning | 2 | 2008 | 1737 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22140 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2008 | 268 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7046 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1901 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 1111 | 0.020 |
Why?
|
Hyperemia | 1 | 2008 | 225 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2872 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1993 | 1504 | 0.020 |
Why?
|
Indoles | 1 | 1995 | 1830 | 0.020 |
Why?
|
Dendritic Spines | 1 | 2008 | 242 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 3702 | 0.020 |
Why?
|
Half-Life | 1 | 2007 | 649 | 0.020 |
Why?
|
Piperidines | 1 | 1995 | 1656 | 0.020 |
Why?
|
Muscles | 1 | 1991 | 1568 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2000 | 2477 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2006 | 611 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2015 | 1910 | 0.020 |
Why?
|
Microtubules | 1 | 2011 | 1071 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2000 | 4947 | 0.020 |
Why?
|
Cattle | 1 | 1991 | 3818 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
Lysosomes | 1 | 2010 | 921 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1967 | 0.020 |
Why?
|
Sample Size | 1 | 2008 | 843 | 0.010 |
Why?
|
RNA Interference | 1 | 2013 | 2816 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1577 | 0.010 |
Why?
|
Self Efficacy | 1 | 2008 | 636 | 0.010 |
Why?
|
Drosophila | 1 | 2011 | 1495 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12985 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2004 | 111 | 0.010 |
Why?
|
Receptors, Notch | 1 | 2008 | 743 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16952 | 0.010 |
Why?
|
Conditioning, Operant | 1 | 2004 | 309 | 0.010 |
Why?
|
Stromal Cells | 1 | 2009 | 1329 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2005 | 725 | 0.010 |
Why?
|
Quinoxalines | 1 | 2004 | 296 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2013 | 7851 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 438 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3571 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5778 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4851 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2011 | 3388 | 0.010 |
Why?
|
Formazans | 1 | 2000 | 8 | 0.010 |
Why?
|
Endopeptidase K | 1 | 2000 | 23 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2410 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 1088 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 2000 | 92 | 0.010 |
Why?
|
Double-Blind Method | 3 | 2000 | 12341 | 0.010 |
Why?
|
Isoelectric Point | 1 | 2000 | 76 | 0.010 |
Why?
|
Mesencephalon | 1 | 2003 | 332 | 0.010 |
Why?
|
Sodium Hydroxide | 1 | 2000 | 37 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 680 | 0.010 |
Why?
|
Neocortex | 1 | 2004 | 416 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2009 | 1683 | 0.010 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2000 | 161 | 0.010 |
Why?
|
Collagen | 1 | 2009 | 2635 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1429 | 0.010 |
Why?
|
Codeine | 1 | 2000 | 51 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2406 | 0.010 |
Why?
|
Static Electricity | 1 | 2000 | 260 | 0.010 |
Why?
|
Biopolymers | 1 | 2000 | 183 | 0.010 |
Why?
|
Filtration | 1 | 2000 | 228 | 0.010 |
Why?
|
Cytosol | 1 | 2003 | 883 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2004 | 1558 | 0.010 |
Why?
|
Ovary | 1 | 2004 | 957 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 665 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 839 | 0.010 |
Why?
|
Solvents | 1 | 2000 | 294 | 0.010 |
Why?
|
Hot Temperature | 1 | 2006 | 1434 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2004 | 1075 | 0.010 |
Why?
|
Fear | 1 | 2008 | 1477 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 4015 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1668 | 0.010 |
Why?
|
Elbow | 1 | 1999 | 130 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1998 | 259 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2008 | 2725 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.010 |
Why?
|
Myocardium | 1 | 1991 | 4746 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2004 | 1891 | 0.010 |
Why?
|
Heart | 1 | 1991 | 4431 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2981 | 0.010 |
Why?
|
Culture Media | 1 | 1999 | 894 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 812 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5250 | 0.010 |
Why?
|
Elbow Joint | 1 | 2000 | 359 | 0.010 |
Why?
|
Pregnancy | 2 | 2012 | 29893 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 1318 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 1334 | 0.010 |
Why?
|
Acetaminophen | 1 | 2000 | 555 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2004 | 3155 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8519 | 0.010 |
Why?
|
Dopamine | 1 | 2003 | 1601 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2000 | 3057 | 0.010 |
Why?
|
Pain Threshold | 1 | 1999 | 603 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1995 | 366 | 0.010 |
Why?
|
Up-Regulation | 1 | 2003 | 4111 | 0.010 |
Why?
|
Neuroglia | 1 | 2000 | 953 | 0.010 |
Why?
|
Receptors, Neurokinin-1 | 1 | 1994 | 134 | 0.010 |
Why?
|
Cholesterol | 1 | 2003 | 2902 | 0.010 |
Why?
|
Substance P | 1 | 1994 | 334 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8003 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1994 | 427 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4014 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1995 | 1308 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 9319 | 0.010 |
Why?
|
Quinpirole | 1 | 1992 | 32 | 0.010 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1992 | 54 | 0.010 |
Why?
|
Ergolines | 1 | 1992 | 57 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15308 | 0.010 |
Why?
|
Glutamates | 1 | 1993 | 385 | 0.010 |
Why?
|
Callithrix | 1 | 1992 | 95 | 0.010 |
Why?
|
Parkinson Disease, Secondary | 1 | 1992 | 122 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6180 | 0.010 |
Why?
|
Portal Vein | 1 | 1994 | 432 | 0.010 |
Why?
|
Levodopa | 1 | 1992 | 222 | 0.010 |
Why?
|
Dopamine Agents | 1 | 1992 | 189 | 0.010 |
Why?
|
Benzazepines | 1 | 1992 | 310 | 0.010 |
Why?
|
Astrocytoma | 1 | 1994 | 774 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 12728 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 14025 | 0.000 |
Why?
|
Trachea | 1 | 1995 | 1090 | 0.000 |
Why?
|
Aspirin | 1 | 2000 | 3129 | 0.000 |
Why?
|
Aging | 1 | 2006 | 8702 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2008 | 64681 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6124 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10203 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20588 | 0.000 |
Why?
|
Movement | 1 | 1992 | 1476 | 0.000 |
Why?
|
Swine | 1 | 1993 | 5909 | 0.000 |
Why?
|
Exercise | 1 | 1999 | 5874 | 0.000 |
Why?
|
Kidney | 1 | 1993 | 7033 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1999 | 39126 | 0.000 |
Why?
|